Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Muijen, Matt
2012.
The state of psychiatry in Europe: Facing the challenges, developing consensus.
International Review of Psychiatry,
Vol. 24,
Issue. 4,
p.
274.
Rüther, T.
Bobes, J.
De Hert, M.
Svensson, T.H.
Mann, K.
Batra, A.
Gorwood, P.
and
Möller, H.J.
2014.
EPA Guidance on Tobacco Dependence and Strategies for Smoking Cessation in People with Mental Illness.
European Psychiatry,
Vol. 29,
Issue. 2,
p.
65.
Gaebel, W.
2014.
EPA-1463 – EPA guidance and the Future of European Psychiatry.
European Psychiatry,
Vol. 29,
Issue. ,
p.
1.
Schmidt, S.J.
Schultze-Lutter, F.
Schimmelmann, B.G.
Maric, N.P.
Salokangas, R.K.R.
Riecher-Rössler, A.
van der Gaag, M.
Meneghelli, A.
Nordentoft, M.
Marshall, M.
Morrison, A.
Raballo, A.
Klosterkötter, J.
and
Ruhrmann, S.
2015.
EPA guidance on the early intervention in clinical high risk states of psychoses.
European Psychiatry,
Vol. 30,
Issue. 3,
p.
388.
Schultze-Lutter, F.
Michel, C.
Schmidt, S.J.
Schimmelmann, B.G.
Maric, N.P.
Salokangas, R.K.R.
Riecher-Rössler, A.
van der Gaag, M.
Nordentoft, M.
Raballo, A.
Meneghelli, A.
Marshall, M.
Morrison, A.
Ruhrmann, S.
and
Klosterkötter, J.
2015.
EPA guidance on the early detection of clinical high risk states of psychoses.
European Psychiatry,
Vol. 30,
Issue. 3,
p.
405.
Heun, R.
and
Gaebel, W.
2015.
The relevance of EPA guidance papers in the framework of the European Psychiatric Association.
European Psychiatry,
Vol. 30,
Issue. 3,
p.
357.
Gaebel, Wolfgang
2016.
The EPA guidance document series.
European Archives of Psychiatry and Clinical Neuroscience,
Vol. 266,
Issue. 2,
p.
87.
Gaebel, W.
2017.
How Can Guidance Recommendations Contribute to Better Mental Health?.
European Psychiatry,
Vol. 41,
Issue. S1,
p.
S12.
Schultze-Lutter, Frauke
Schnyder, Nina
Michel, Chantal
and
Schmidt, Stefanie J.
2019.
Handbook of Attenuated Psychosis Syndrome Across Cultures.
p.
115.
Musil, Richard
and
Falkai, Peter
2020.
NeuroPsychopharmacotherapy.
p.
1.
Galderisi, S.
Mucci, A.
Dollfus, S.
Nordentoft, M.
Falkai, P.
Kaiser, S.
Giordano, G. M.
Vandevelde, A.
Nielsen, M. Ø.
Glenthøj, L. B.
Sabé, M.
Pezzella, P.
Bitter, I.
and
Gaebel, W.
2021.
EPA guidance on assessment of negative symptoms in schizophrenia.
European Psychiatry,
Vol. 64,
Issue. 1,
Galderisi, S.
Kaiser, S.
Bitter, I.
Nordentoft, M.
Mucci, A.
Sabé, M.
Giordano, G. M.
Nielsen, M. Ø.
Glenthøj, L. B.
Pezzella, P.
Falkai, P.
Dollfus, S.
and
Gaebel, W.
2021.
EPA guidance on treatment of negative symptoms in schizophrenia.
European Psychiatry,
Vol. 64,
Issue. 1,
Vita, Antonio
Gaebel, Wolfgang
Mucci, Armida
Sachs, Gabriele
Erfurth, Andreas
Barlati, Stefano
Zanca, Federico
Giordano, Giulia Maria
Birkedal Glenthøj, Louise
Nordentoft, Merete
and
Galderisi, Silvana
2022.
European Psychiatric Association guidance on assessment of cognitive impairment in schizophrenia.
European Psychiatry,
Vol. 65,
Issue. 1,
Vita, Antonio
Gaebel, Wolfgang
Mucci, Armida
Sachs, Gabriele
Barlati, Stefano
Giordano, Giulia Maria
Nibbio, Gabriele
Nordentoft, Merete
Wykes, Til
and
Galderisi, Silvana
2022.
European Psychiatric Association guidance on treatment of cognitive impairment in schizophrenia.
European Psychiatry,
Vol. 65,
Issue. 1,
Paterlini, Federica
2022.
Esordi psicotici in adolescenza e giovane età adulta: prospettive teoriche e di trattamento.
RIVISTA SPERIMENTALE DI FRENIATRIA,
Vol. 146,
Issue. 3,
p.
31.
Musil, Richard
and
Falkai, Peter
2022.
NeuroPsychopharmacotherapy.
p.
671.
Comments
No Comments have been published for this article.